These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19188828)

  • 1. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
    Yoshikawa M; Nakamura K; Nagase S; Sakuragi S; Kusano KF; Matsubara H; Ohe T
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):179-86. PubMed ID: 19188828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined treatment with statin and angiotensin-receptor blocker after stenting as a useful strategy for prevention of coronary restenosis.
    Nishikawa H; Miura S; Shimomura H; Tsujita K; Okamura K; Zhang B; Iwata A; Shirai K; Matsuo K; Arai H; Saku K
    J Cardiol; 2005 Mar; 45(3):107-13. PubMed ID: 15801275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of antihypertensive therapy with add-on angiotensin II type 1 receptor blocker after successful coronary stent implantation.
    Sugihara M; Miura S; Takamiya Y; Kiya Y; Arimura T; Iwata A; Kawamura A; Nishikawa H; Uehara Y; Saku K
    Hypertens Res; 2009 Jul; 32(7):625-30. PubMed ID: 19461652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-dimensional fluorescence in-gel electrophoresis of coronary restenosis tissues in minipigs: increased adipocyte fatty acid binding protein induces reactive oxygen species-mediated growth and migration in smooth muscle cells.
    Lu L; Wang YN; Sun WH; Liu ZH; Zhang Q; Pu LJ; Yang K; Wang LJ; Zhu ZB; Meng H; Yang P; Du R; Chen QJ; Wang LS; Yu H; Shen WF
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):572-80. PubMed ID: 23372061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
    Voisard R; Krebs R; Baur R; Hombach V
    Coron Artery Dis; 2010 Aug; 21(5):286-91. PubMed ID: 20508518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local statin therapy differentially interferes with smooth muscle and endothelial cell proliferation and reduces neointima on a drug-eluting stent platform.
    Jaschke B; Michaelis C; Milz S; Vogeser M; Mund T; Hengst L; Kastrati A; Schömig A; Wessely R
    Cardiovasc Res; 2005 Dec; 68(3):483-92. PubMed ID: 16111664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restenosis after successful ostial stent implantation: the role of statins compared with conventional treatment.
    Horlitz M; Amin FR; Boerrigter G; Sigwart U; Clague JR
    J Interv Cardiol; 2004 Oct; 17(5):301-6. PubMed ID: 15491333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
    Wessely R; Blaich B; Belaiba RS; Merl S; Görlach A; Kastrati A; Schömig A
    Thromb Haemost; 2007 Jun; 97(6):1003-12. PubMed ID: 17549304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammation.
    Bonta PI; Pols TW; van Tiel CM; Vos M; Arkenbout EK; Rohlena J; Koch KT; de Maat MP; Tanck MW; de Winter RJ; Pannekoek H; Biessen EA; Bot I; de Vries CJ
    Circulation; 2010 May; 121(18):2023-32. PubMed ID: 20421523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury.
    Hur KY; Seo HJ; Kang ES; Kim SH; Song S; Kim EH; Lim S; Choi C; Heo JH; Hwang KC; Ahn CW; Cha BS; Jung M; Lee HC
    Eur J Pharmacol; 2008 May; 586(1-3):226-33. PubMed ID: 18387604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of statins on restenosis after coronary stent implantation.
    Kamishirado H; Inoue T; Sakuma M; Tsuda T; Hayashi T; Takayanagi K; Node K
    Angiology; 2007; 58(1):55-60. PubMed ID: 17351158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants relieve phosphatase inhibition and reduce PDGF signaling in cultured VSMCs and in restenosis.
    Kappert K; Sparwel J; Sandin A; Seiler A; Siebolts U; Leppänen O; Rosenkranz S; Ostman A
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2644-51. PubMed ID: 16990553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The involvement of vascular endothelial growth factor and flt-1 in the process of neointimal proliferation in pig coronary arteries following stent implantation.
    Shibata M; Suzuki H; Nakatani M; Koba S; Geshi E; Katagiri T; Takeyama Y
    Histochem Cell Biol; 2001 Dec; 116(6):471-81. PubMed ID: 11810189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53.
    Wang X; Zou Y; Sun A; Xu D; Niu Y; Wang S; Wang K; Ge J
    J Cardiovasc Pharmacol; 2007 May; 49(5):253-60. PubMed ID: 17513942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA; Griffin MO; Guttormsen B; Stoker S; Wolff MR
    J Invasive Cardiol; 2007 Jun; 19(6):269-74. PubMed ID: 17541129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of simvastatin on platelet-derived growth factor signaling in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension.
    Ikeda T; Nakamura K; Akagi S; Kusano KF; Matsubara H; Fujio H; Ogawa A; Miura A; Miura D; Oto T; Yamanaka R; Otsuka F; Date H; Ohe T; Ito H
    J Cardiovasc Pharmacol; 2010 Jan; 55(1):39-48. PubMed ID: 19786891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cytochalasin D-eluting stents on intimal hyperplasia in a porcine coronary artery model.
    Salu KJ; Bosmans JM; Huang Y; Hendriks M; Verhoeven M; Levels A; Cooper S; De Scheerder IK; Vrints CJ; Bult H
    Cardiovasc Res; 2006 Feb; 69(2):536-44. PubMed ID: 16386237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
    Yamawaki T; Yamada A; Fukumoto Y; Kishi T; Sobashima A; Kuwata K; Nakamura R; Sekiya M; Ando H; Okamatsu S
    Fukuoka Igaku Zasshi; 2007 Jun; 98(6):260-9. PubMed ID: 17665547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protease-activated receptor-1 antagonist F 16618 reduces arterial restenosis by down-regulation of tumor necrosis factor α and matrix metalloproteinase 7 expression, migration, and proliferation of vascular smooth muscle cells.
    Chieng-Yane P; Bocquet A; Létienne R; Bourbon T; Sablayrolles S; Perez M; Hatem SN; Lompré AM; Le Grand B; David-Dufilho M
    J Pharmacol Exp Ther; 2011 Mar; 336(3):643-51. PubMed ID: 21139058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined vascular effects of HMG-CoA reductase inhibitor and angiotensin receptor blocker in non-diabetic patients undergoing peritoneal dialysis.
    Han SH; Kang EW; Yoon SJ; Yoon HS; Lee HC; Yoo TH; Choi KH; Han DS; Kang SW
    Nephrol Dial Transplant; 2011 Nov; 26(11):3722-8. PubMed ID: 21385862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.